Methyl N-[1-[(2S)-2-[5-[6-(1,3-benzoxazol-2-yl)-1-fluoro-3-[2-[(2S)-1-[2-(methoxycarbonylamino)-3-methylbutanoyl]pyrrolidin-2-yl]-1H-imidazol-5-yl]-6H-indolo[1,2-c][1,3]benzoxazin-10-yl]-1H-imidazol-2-yl]pyrrolidin-1-yl]-3-methyl-1-oxobutan-2-yl]carbamate
C50H53FN10O8 — CID 146588297
Data last refreshed: (MolForge compound catalog, from PubChem)
About Methyl N-[1-[(2S)-2-[5-[6-(1,3-benzoxazol-2-yl)-1-fluoro-3-[2-[(2S)-1-[2-(methoxycarbonylamino)-3-methylbutanoyl]pyrrolidin-2-yl]-1H-imidazol-5-yl]-6H-indolo[1,2-c][1,3]benzoxazin-10-yl]-1H-imidazol-2-yl]pyrrolidin-1-yl]-3-methyl-1-oxobutan-2-yl]carbamate
Methyl N-[1-[(2S)-2-[5-[6-(1,3-benzoxazol-2-yl)-1-fluoro-3-[2-[(2S)-1-[2-(methoxycarbonylamino)-3-methylbutanoyl]pyrrolidin-2-yl]-1H-imidazol-5-yl]-6H-indolo[1,2-c][1,3]benzoxazin-10-yl]-1H-imidazol-2-yl]pyrrolidin-1-yl]-3-methyl-1-oxobutan-2-yl]carbamate (PubChem CID 146588297) has the molecular formula C50H53FN10O8 and a molecular weight of 941.03 g/mol. Its IUPAC name is methyl N-[1-[(2S)-2-[5-[6-(1,3-benzoxazol-2-yl)-1-fluoro-3-[2-[(2S)-1-[2-(methoxycarbonylamino)-3-methylbutanoyl]pyrrolidin-2-yl]-1H-imidazol-5-yl]-6H-indolo[1,2-c][1,3]benzoxazin-10-yl]-1H-imidazol-2-yl]pyrrolidin-1-yl]-3-methyl-1-oxobutan-2-yl]carbamate.
Molecular Properties
| Compound Name | Methyl N-[1-[(2S)-2-[5-[6-(1,3-benzoxazol-2-yl)-1-fluoro-3-[2-[(2S)-1-[2-(methoxycarbonylamino)-3-methylbutanoyl]pyrrolidin-2-yl]-1H-imidazol-5-yl]-6H-indolo[1,2-c][1,3]benzoxazin-10-yl]-1H-imidazol-2-yl]pyrrolidin-1-yl]-3-methyl-1-oxobutan-2-yl]carbamate |
|---|---|
| PubChem CID | 146588297 |
| Molecular Formula | C50H53FN10O8 |
| Molecular Weight | 941.03 g/mol |
| Exact Mass | 940.40 |
| IUPAC Name | methyl N-[1-[(2S)-2-[5-[6-(1,3-benzoxazol-2-yl)-1-fluoro-3-[2-[(2S)-1-[2-(methoxycarbonylamino)-3-methylbutanoyl]pyrrolidin-2-yl]-1H-imidazol-5-yl]-6H-indolo[1,2-c][1,3]benzoxazin-10-yl]-1H-imidazol-2-yl]pyrrolidin-1-yl]-3-methyl-1-oxobutan-2-yl]carbamate |
| SMILES | COC(=O)NC(C(=O)N1CCC[C@H]1c1ncc(-c2cc(F)c3c(c2)OC(c2nc4ccccc4o2)n2c-3cc3cc(-c4cnc([C@@H]5CCCN5C(=O)C(NC(=O)OC)C(C)C)[nH]4)ccc32)[nH]1)C(C)C |
| InChI | InChI=1S/C50H53FN10O8/c1-25(2)41(57-49(64)66-5)46(62)59-17-9-12-35(59)43-52-23-32(54-43)27-15-16-34-29(19-27)21-37-40-30(51)20-28(22-39(40)69-48(61(34)37)45-56-31-11-7-8-14-38(31)68-45)33-24-53-44(55-33)36-13-10-18-60(36)47(63)42(26(3)4)58-50(65)67-6/h7-8,11,14-16,19-26,35-36,41-42,48H,9-10,12-13,17-18H2,1-6H3,(H,52,54)(H,53,55)(H,57,64)(H,58,65)/t35-,36-,41?,42?,48?/m0/s1 |
| InChIKey | YHCLVPWDALNQET-FZOBTKHBSA-N |
| XLogP | 8.40 |
| TPSA | 214.83 Ų |
| H-Bond Donors | 4 |
| H-Bond Acceptors | 12 |
| Rotatable Bonds | 11 |
| Heavy Atoms | 69 |
| Complexity | — |
Lipinski Rule of Five
3 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 941.03 |
| LogP ≤ 5 | 8.40 |
| H-Bond Donors ≤ 5 | 4 |
| H-Bond Acceptors ≤ 10 | 12 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 146588297 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.